4th Quarter - Report

CAPITOL CITY GROUP, LTD. for ARDELYX, INC.

Firm
Client
Income
$20,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Assist client with legislation re: Kidney Patient Act; monitor legislation re: same. HR 5074-Kidney PATIENT Act of 2023; S 4510 Kidney PATIENT Act of 2024; Kidney Patient Access to Technologically Innovative and Essential Nephrology Treatments Act of 2024. HR 6790 New "Era of Preventing End-Stage Kidney Disease Act; HR 5027-S4469 Kidney Disease Improvement in Research and Treatment Act of 2024.

LobbyistCovered position, as disclosed
GERALD T HARRINGTON —
CHRISTOPHER PAUL VITALE —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 6790 (118th), H.R. 5074 (118th), H.R. 5027 (118th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.